{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:04:40Z","timestamp":1790813080094,"version":"4.1.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.14283\/jpad.2023.105","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T08:18:16Z","timestamp":1698135496000},"page":"647-660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Fibrin-Targeting Immunotherapy for Dementia"],"prefix":"10.1016","volume":"10","author":[{"given":"A.B.","family":"Kantor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Akassoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Stavenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.14283\/jpad.2023.105_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ana.25123","article-title":"Person-specific contribution of neuropathologies to cognitive loss in old age","volume":"83","author":"Boyle","year":"2018","journal-title":"Ann Neurol"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.22112","article-title":"Cerebral amyloid angiopathy pathology and cognitive domains in older persons","volume":"69","author":"Arvanitakis","year":"2011","journal-title":"Ann Neurol"},{"key":"10.14283\/jpad.2023.105_bib4","author":"Eli_Lilly"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13024-023-00637-0","article-title":"Anti-amyloid therapies for Alzheimer disease: finally, good news for patients","volume":"18","author":"Ramanan","year":"2023","journal-title":"Mol. Neurodegen"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib7","first-page":"211","article-title":"Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy","volume":"9","author":"Barakos","year":"2022","journal-title":"JPAD"},{"issue":"9","key":"10.14283\/jpad.2023.105_bib8","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3174\/ajnr.A7586","article-title":"Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice","volume":"43","author":"Cogswell","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.14283\/jpad.2023.105_bib9","doi-asserted-by":"crossref","first-page":"862369","DOI":"10.3389\/fneur.2022.862369","article-title":"Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease","volume":"13","author":"Withington","year":"2022","journal-title":"Front Neurol"},{"issue":"8","key":"10.14283\/jpad.2023.105_bib10","doi-asserted-by":"crossref","first-page":"7258","DOI":"10.3390\/ijms24087258","article-title":"Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer's Disease","volume":"24","author":"Afsar","year":"2023","journal-title":"Int. J. of Mol. Sci."},{"issue":"1","key":"10.14283\/jpad.2023.105_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3934\/Neuroscience.2021005","article-title":"The biological pathways of Alzheimer disease: a review","volume":"8","author":"Calabr\u00f6","year":"2021","journal-title":"AIMS Neurosci"},{"issue":"4","key":"10.14283\/jpad.2023.105_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib13","doi-asserted-by":"crossref","first-page":"e12385","DOI":"10.1002\/trc2.12385","article-title":"Alzheimer's disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.14283\/jpad.2023.105_bib14","doi-asserted-by":"crossref","first-page":"1196413","DOI":"10.3389\/fphar.2023.1196413","article-title":"Alzheimer's disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?","volume":"14","author":"Melchiorri","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.14283\/jpad.2023.105_bib15","unstructured":"Therini Bio Initiates First-In-Human Dosing in Phase 1 Trial of THN391, a Fibrin-Targeting Therapeutic Candidate for Alzheimer's Disease [press release]. 2023."},{"key":"10.14283\/jpad.2023.105_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/brain\/awu393","article-title":"Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly","volume":"138","author":"Vemuri","year":"2015","journal-title":"Brain"},{"issue":"9","key":"10.14283\/jpad.2023.105_bib17","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaneurol.2018.1123","article-title":"Interactive Associations of Vascular Risk and beta-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study","volume":"75","author":"Rabin","year":"2018","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.14283\/jpad.2023.105_bib18","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer's disease: A matter of blood-brain barrier dysfunction?","volume":"214","author":"Montagne","year":"2017","journal-title":"J Exp Med"},{"issue":"3","key":"10.14283\/jpad.2023.105_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s42003-023-04717-1","article-title":"Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer's disease?","volume":"6","author":"Petrovskaya","year":"2023","journal-title":"Communications Biology"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jalz.2017.07.755","article-title":"Concomitant vascular and neurodegenerative pathologies double the risk of dementia","volume":"14","author":"Azarpazhooh","year":"2018","journal-title":"Alzheimer's Dement"},{"issue":"6","key":"10.14283\/jpad.2023.105_bib22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3390\/cells12060962","article-title":"Biomarkers Assessing Endothelial Dysfunction in Alzheimer's Disease","volume":"12","author":"Custodia","year":"2023","journal-title":"Cells"},{"key":"10.14283\/jpad.2023.105_bib23","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain"},{"issue":"5","key":"10.14283\/jpad.2023.105_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuron.2010.05.014","article-title":"Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease","volume":"66","author":"Cortes-Canteli","year":"2010","journal-title":"Neuron"},{"issue":"12","key":"10.14283\/jpad.2023.105_bib25","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.jcbfm.9600155","article-title":"Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex","volume":"25","author":"Cullen","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease","volume":"36","author":"Halliday","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"10.14283\/jpad.2023.105_bib27","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/jcbfm.2013.76","article-title":"The APOE \u03b54\/\u03b54 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients","volume":"33","author":"Hultman","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9A","key":"10.14283\/jpad.2023.105_bib28","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1111\/j.1582-4934.2008.00434.x","article-title":"A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain","volume":"13","author":"Ryu","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10.14283\/jpad.2023.105_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bpa.12004","article-title":"Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathol"},{"issue":"7","key":"10.14283\/jpad.2023.105_bib30","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2006.05.016","article-title":"Microvascular injury and blood-brain barrier leakage in Alzheimer's disease","volume":"28","author":"Zipser","year":"2007","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0271678X17690761","article-title":"Differing associations between A\u03b2 accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease","volume":"38","author":"Miners","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"10.14283\/jpad.2023.105_bib32","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neuron.2019.01.014","article-title":"Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model","volume":"101","author":"Merlini","year":"2019","journal-title":"Neuron"},{"key":"10.14283\/jpad.2023.105_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-0716-2655-9_5","article-title":"Three-Dimensional Imaging of Fibrinogen and Neurovascular Alterations in Alzheimer's Disease","volume":"2561","author":"Merlini","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.14283\/jpad.2023.105_bib34","doi-asserted-by":"crossref","first-page":"695479","DOI":"10.3389\/fncel.2021.695479","article-title":"Relationship Between Amyloid-\u03b2 Deposition and Blood-Brain Barrier Dysfunction in Alzheimer's Disease","volume":"15","author":"Wang","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.14283\/jpad.2023.105_bib35","doi-asserted-by":"crossref","first-page":"583931","DOI":"10.1155\/2015\/583931","article-title":"Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer","volume":"2015","author":"Bailly","year":"2015","journal-title":"Biomed Res Int"},{"issue":"7","key":"10.14283\/jpad.2023.105_bib36","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2967\/jnumed.113.130161","article-title":"Activity of P-Glycoprotein, a \u03b2-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease","volume":"55","author":"Deo","year":"2014","journal-title":"J Nucl Med"},{"key":"10.14283\/jpad.2023.105_bib37","doi-asserted-by":"crossref","first-page":"107554","DOI":"10.1016\/j.pharmthera.2020.107554","article-title":"Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders","volume":"213","author":"Gil-Martins","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.14283\/jpad.2023.105_bib38","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3390\/ijms22042110","article-title":"Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring","volume":"22","author":"van Oostveen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.14283\/jpad.2023.105_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pscychresns.2006.12.003","article-title":"Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease","volume":"155","author":"Hunt","year":"2007","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.14283\/jpad.2023.105_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.14283\/jpad.2023.105_bib41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.13104\/imri.2022.26.4.256","article-title":"Dynamic Contrast-Enhanced MRI and Its Applications in Various Central Nervous System Diseases","volume":"26","author":"Kim","year":"2022","journal-title":"Investig Magn Reson Imaging"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib42","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat Med"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1148\/radiol.2016152244","article-title":"Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease","volume":"281","author":"van de Haar","year":"2016","journal-title":"Radiology"},{"key":"10.14283\/jpad.2023.105_bib45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2016.06.006","article-title":"Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging","volume":"45","author":"van de Haar","year":"2016","journal-title":"Neurobiol Aging"},{"issue":"7806","key":"10.14283\/jpad.2023.105_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.14283\/jpad.2023.105_bib47","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1177\/0271678X20952012","article-title":"Hippocampal blood-brain barrier permeability is related to the APOE4 mutation status of elderly individuals without dementia","volume":"41","author":"Moon","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"10.14283\/jpad.2023.105_bib48","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41591-020-0886-4","article-title":"Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes","volume":"26","author":"Blanchard","year":"2020","journal-title":"Nat Med"},{"issue":"01","key":"10.14283\/jpad.2023.105_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/0004-282x-anp-2020-0094","article-title":"Blood-cerebrospinal fluid (CSF) barrier dysfunction means reduced CSF flow not barrier leakage - conclusions from CSF protein data","volume":"79","author":"Reiber","year":"2021","journal-title":"Arquivos de Neuro-Psiquiatria"},{"key":"10.14283\/jpad.2023.105_bib50","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2016.11.017","article-title":"Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype","volume":"51","author":"Janelidze","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.14283\/jpad.2023.105_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.06.028","article-title":"CSF\/serum albumin ratio in dementias: a cross-sectional study on 1861 patients","volume":"59","author":"Skillb\u00e4ck","year":"2017","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.14283\/jpad.2023.105_bib52","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/WNL.50.4.966","article-title":"A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia","volume":"50","author":"Skoog","year":"1998","journal-title":"Neurology"},{"issue":"9","key":"10.14283\/jpad.2023.105_bib53","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1001\/jamaneurol.2013.3841","article-title":"Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown","volume":"70","author":"Halliday","year":"2013","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.14283\/jpad.2023.105_bib54","first-page":"e12782","article-title":"Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies. Neuropathol. Appl","volume":"48","author":"Kurz","year":"2022","journal-title":"Neurobiol"},{"key":"10.14283\/jpad.2023.105_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2015.09.025","article-title":"Shedding of soluble platelet-derived growth factor receptor-\u03b2 from human brain pericytes","volume":"607","author":"Sagare","year":"2015","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13195-019-0534-8","article-title":"CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology","volume":"11","author":"Miners","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2023.105_bib57","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neurobiolaging.2019.09.020","article-title":"Linking APOE-\u03b54, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology","volume":"85","author":"Riphagen","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.14283\/jpad.2023.105_bib58","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207358","article-title":"Associations of CSF PDGFR\u03b2 With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic Changes","author":"Cicognola","year":"2023","journal-title":"Neurology"},{"issue":"3","key":"10.14283\/jpad.2023.105_bib59","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/head.14088","article-title":"Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen","volume":"61","author":"Cowan","year":"2021","journal-title":"Headache"},{"issue":"6","key":"10.14283\/jpad.2023.105_bib60","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/alz.12061","article-title":"A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid","volume":"16","author":"Sweeney","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-021-00512-w","article-title":"Dynamic changes of CSF sPDGFR\u03b2 during ageing and AD progression and associations with CSF ATN biomarkers. Mol","volume":"17","author":"Wang","year":"2022","journal-title":"Neurodegener"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib62","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neurobiolaging.2014.10.030","article-title":"Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration","volume":"36","author":"Cortes-Canteli","year":"2015","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.14283\/jpad.2023.105_bib64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnagi.2014.00032","article-title":"Imaging of cerebrovascular pathology in animal models of Alzheimer's disease","volume":"6","author":"Klohs","year":"2014","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"10.14283\/jpad.2023.105_bib65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrn.2018.13","article-title":"Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics","volume":"19","author":"Petersen","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"25","key":"10.14283\/jpad.2023.105_bib66","doi-asserted-by":"crossref","first-page":"14482","DOI":"10.1073\/pnas.1921327117","article-title":"Cerebral amyloid angiopathy-linked \u03b2-amyloid mutations promote cerebral fibrin deposits via increased binding affinity for fibrinogen","volume":"117","author":"Cajamarca","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.14283\/jpad.2023.105_bib67","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20070304","article-title":"Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease","volume":"204","author":"Paul","year":"2007","journal-title":"J Exp Med"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0206-2","article-title":"The overlap between vascular disease and Alzheimer's disease-lessons from pathology","volume":"12","author":"Attems","year":"2014","journal-title":"BMC medicine"},{"issue":"22","key":"10.14283\/jpad.2023.105_bib69","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","article-title":"Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons","volume":"85","author":"Boyle","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.14283\/jpad.2023.105_bib70","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbadis.2015.12.023","article-title":"Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons","volume":"1862","author":"Kapasi","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"50","key":"10.14283\/jpad.2023.105_bib71","doi-asserted-by":"crossref","first-page":"21812","DOI":"10.1073\/pnas.1010373107","article-title":"Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization","volume":"107","author":"Ahn","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.14283\/jpad.2023.105_bib72","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood-2016-03-705228","article-title":"Biochemical and structural analysis of the interaction between \u03b2-amyloid and fibrinogen","volume":"128","author":"Zamolodchikov","year":"2016","journal-title":"Blood"},{"issue":"14","key":"10.14283\/jpad.2023.105_bib73","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1182\/blood-2011-11-389668","article-title":"Abeta delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin","volume":"119","author":"Zamolodchikov","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.14283\/jpad.2023.105_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030496","article-title":"Epitope Mapping Immunoassay Analysis of the Interaction between \u03b2-Amyloid and Fibrinogen","volume":"20","author":"Van Giau","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib75","first-page":"20","article-title":"Characterization of antibody clones that bind exclusively to insoluble fibrin","volume":"34","author":"Fuchigami","year":"2023","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib76","first-page":"2604","article-title":"Discovery of an uncovered region in fibrin clots and its clinical significance. Sci","volume":"3","author":"Hisada","year":"2013","journal-title":"Rep"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib77","first-page":"id1070","article-title":"Precipitation of Insoluble Fibrin in the Brains of Alzheimer's Disease Model Mice","volume":"10","author":"Osman","year":"2023","journal-title":"J Blood Disord"},{"issue":"3","key":"10.14283\/jpad.2023.105_bib78","first-page":"163","article-title":"Fibrin mechanisms and functions in nervous system pathology","volume":"4","author":"Adams","year":"2004","journal-title":"Mol Interv"},{"issue":"12","key":"10.14283\/jpad.2023.105_bib79","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1161\/01.STR.0000189721.31432.26","article-title":"Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia","volume":"36","author":"van Oijen","year":"2005","journal-title":"Stroke"},{"issue":"7","key":"10.14283\/jpad.2023.105_bib80","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1742-1241.2007.01268.x","article-title":"Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment","volume":"62","author":"Xu","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.dadm.2014.11.005","article-title":"Blood protein predictors of brain amyloid for enrichment in clinical trials?","volume":"1","author":"Ashton","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.14283\/jpad.2023.105_bib82","first-page":"14","article-title":"The Correlations Between Plasma Fibrinogen With Amyloid-Beta and Tau Levels in Patients With Alzheimer's Disease","author":"Fan","year":"2021","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.14283\/jpad.2023.105_bib83","doi-asserted-by":"crossref","first-page":"e18850","DOI":"10.1371\/journal.pone.0018850","article-title":"Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis","volume":"6","author":"Craig-Schapiro","year":"2011","journal-title":"PLoS One"},{"key":"10.14283\/jpad.2023.105_bib84","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2377-7-14","article-title":"Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease","volume":"7","author":"Lee","year":"2007","journal-title":"BMC Neurol"},{"issue":"3","key":"10.14283\/jpad.2023.105_bib85","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3233\/JAD-2011-111505","article-title":"Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid","volume":"28","author":"Vafadar-Isfahani","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"10.14283\/jpad.2023.105_bib86","doi-asserted-by":"crossref","first-page":"e28527","DOI":"10.1371\/journal.pone.0028527","article-title":"Plasma biomarkers of brain atrophy in Alzheimer's disease","volume":"6","author":"Thambisetty","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.14283\/jpad.2023.105_bib87","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3233\/JAD-132102","article-title":"Prognostic polypeptide blood plasma biomarkers of Alzheimer's disease progression","volume":"40","author":"Yang","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"10.14283\/jpad.2023.105_bib88","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","article-title":"Fibrinogen and fibrin structure and functions","volume":"3","author":"Mosesson","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib89","first-page":"161","article-title":"Fibrinogen and fibrin: An illustrated review","volume":"3","author":"Pieters","year":"2019","journal-title":"RPTH"},{"key":"10.14283\/jpad.2023.105_bib90","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fncel.2015.00354","article-title":"Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface","volume":"9","author":"Bardehle","year":"2015","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"10.14283\/jpad.2023.105_bib91","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0092-8674(00)81390-2","article-title":"Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency","volume":"87","author":"Bugge","year":"1996","journal-title":"Cell"},{"issue":"3","key":"10.14283\/jpad.2023.105_bib92","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.20061931","article-title":"The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease","volume":"204","author":"Adams","year":"2007","journal-title":"J Exp Med"},{"key":"10.14283\/jpad.2023.105_bib93","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1038\/ncomms9164","article-title":"Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation","volume":"6","author":"Ryu","year":"2015","journal-title":"Nat Commun"},{"issue":"31","key":"10.14283\/jpad.2023.105_bib94","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1021\/bi034057k","article-title":"Sequence gamma 377\u2013395(P2), but not gamma 190\u2013202(P1), is the binding site for the alpha MI-domain of integrin alpha M beta 2 in the gamma C-domain of fibrinogen","volume":"42","author":"Ugarova","year":"2003","journal-title":"Biochemistry"},{"key":"10.14283\/jpad.2023.105_bib95","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1749-6632.2001.tb03523.x","article-title":"Recognition of fibrinogen by leukocyte integrins","volume":"936","author":"Ugarova","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"6575","key":"10.14283\/jpad.2023.105_bib96","doi-asserted-by":"crossref","first-page":"eabl5450","DOI":"10.1126\/science.abl5450","article-title":"Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier","volume":"374","author":"Silva","year":"2021","journal-title":"Science"},{"issue":"7","key":"10.14283\/jpad.2023.105_bib97","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41590-023-01542-w","article-title":"Fibrin induces neurotoxic microglia gene programs in neurodegeneration","volume":"24","author":"Mendiola","year":"2023","journal-title":"Nat Immunol"},{"key":"10.14283\/jpad.2023.105_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/s41590-023-01522-0","article-title":"Defining blood-induced microglia functions in neurodegeneration through multiomic profiling","author":"Mendiola","year":"2023","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.14283\/jpad.2023.105_bib99","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41590-018-0232-x","article-title":"Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration","volume":"19","author":"Ryu","year":"2018","journal-title":"Nat Immunol"},{"issue":"26","key":"10.14283\/jpad.2023.105_bib100","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1073\/pnas.1805542115","article-title":"Critical role of integrin CD11c in splenic dendritic cell capture of missing-self CD47 cells to induce adaptive immunity","volume":"115","author":"Wu","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s42977-020-00063-z","article-title":"Biologia Futura: stories about the functions of \u03b2(2)-integrins in human phagocytes","volume":"72","author":"Bajtay","year":"2021","journal-title":"Biol Futur"},{"issue":"9","key":"10.14283\/jpad.2023.105_bib102","doi-asserted-by":"crossref","first-page":"e0163120","DOI":"10.1371\/journal.pone.0163120","article-title":"CD11c\/CD18 Dominates Adhesion of Human Monocytes, Macrophages and Dendritic Cells over CD11b\/CD18","volume":"11","author":"S\u00e1ndor","year":"2016","journal-title":"PLOS ONE"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib103","first-page":"20","article-title":"Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes\/macrophages in health and glioma. Acta Neuropathol","volume":"7","author":"Haage","year":"2019","journal-title":"Commun"},{"issue":"7","key":"10.14283\/jpad.2023.105_bib104","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"issue":"22","key":"10.14283\/jpad.2023.105_bib105","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.15252\/embj.201696056","article-title":"A novel microglial subset plays a key role in myelinogenesis in developing brain","volume":"36","author":"Wlodarczyk","year":"2017","journal-title":"Embo j"},{"issue":"7","key":"10.14283\/jpad.2023.105_bib106","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.168142","article-title":"CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization","volume":"8","author":"Droho","year":"2023","journal-title":"JCI Insight"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib107","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12974-020-02010-0","article-title":"Ocular macrophage origin and heterogeneity during steady state and experimental choroidal neovascularization. J","volume":"17","author":"Droho","year":"2020","journal-title":"Neuroinflammation"},{"issue":"4","key":"10.14283\/jpad.2023.105_bib108","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1083\/jcb.200801146","article-title":"Structural basis for distinctive recognition of fibrinogen gammaC peptide by the platelet integrin alphaIIbbeta3","volume":"182","author":"Springer","year":"2008","journal-title":"J Cell Biol"},{"issue":"11","key":"10.14283\/jpad.2023.105_bib109","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1172\/JCI20741","article-title":"Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2\/Mac-1 is critical for host inflammatory response in vivo","volume":"113","author":"Flick","year":"2004","journal-title":"J Clin Invest"},{"issue":"11","key":"10.14283\/jpad.2023.105_bib110","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1172\/JCI30134","article-title":"Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif","volume":"117","author":"Flick","year":"2007","journal-title":"J Clin Invest"},{"key":"10.14283\/jpad.2023.105_bib111","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ncomms2230","article-title":"Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation","volume":"3","author":"Davalos","year":"2012","journal-title":"Nat Commun"},{"issue":"6","key":"10.14283\/jpad.2023.105_bib112","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neuron.2019.03.007","article-title":"Inflaming the Brain","volume":"101","author":"Ahn","year":"2019","journal-title":"Neuron"},{"issue":"3","key":"10.14283\/jpad.2023.105_bib113","first-page":"566","volume":"47","author":"Krasemann","year":"2017","journal-title":"The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases, Immunity"},{"issue":"4","key":"10.14283\/jpad.2023.105_bib114","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","article-title":"The Major Risk Factors for Alzheimer's Disease: Age, Sex, and Genes Modulate the Microglia Response to A\u03b2 Plaques","volume":"27","author":"Sala Frigerio","year":"2019","journal-title":"Cell Rep"},{"issue":"3","key":"10.14283\/jpad.2023.105_bib115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017742118","article-title":"Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's disease","volume":"118","author":"Ellwanger","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib116","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11481-007-9069-z","article-title":"Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice","volume":"2","author":"Herber","year":"2007","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib117","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13073-023-01155-w","article-title":"The neuroimmune axis of Alzheimer's disease","volume":"15","author":"Jorfi","year":"2023","journal-title":"Genome Medicine"},{"issue":"9","key":"10.14283\/jpad.2023.105_bib118","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","article-title":"A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease","volume":"53","author":"Wightman","year":"2021","journal-title":"Nat Genet"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib119","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2017","journal-title":"Journal of Cell Biology"},{"issue":"12","key":"10.14283\/jpad.2023.105_bib120","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","article-title":"Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight","volume":"18","author":"Shi","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.14283\/jpad.2023.105_bib121","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2 - a key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.14283\/jpad.2023.105_bib122","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 Is a Receptor for \u03b2-Amyloid that Mediates Microglial Function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"key":"10.14283\/jpad.2023.105_bib123","author":"Pionyr"},{"key":"10.14283\/jpad.2023.105_bib124","unstructured":"Alector. Press Releases Feb 2022, Aug 2022, Corporate Presentations Jan 2023, May 2023 2023"},{"issue":"4","key":"10.14283\/jpad.2023.105_bib125","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","article-title":"TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"},{"issue":"6","key":"10.14283\/jpad.2023.105_bib126","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib127","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI97509","article-title":"Blood will out: vascular contributions to Alzheimer's disease","volume":"128","author":"Strickland","year":"2018","journal-title":"J Clin Invest"},{"issue":"3","key":"10.14283\/jpad.2023.105_bib128","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nm.4482","article-title":"Pericyte degeneration causes white matter dysfunction in the mouse central nervous system","volume":"24","author":"Montagne","year":"2018","journal-title":"Nat Med"},{"issue":"8","key":"10.14283\/jpad.2023.105_bib129","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.3390\/ijms24087046","article-title":"Vascular Dysfunction in Alzheimer's Disease: Alterations in the Plasma Contact and Fibrinolytic Systems","volume":"24","author":"Badimon","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.14283\/jpad.2023.105_bib130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3233\/JAD-2012-120820","article-title":"Fibrinogen and altered hemostasis in Alzheimer's disease","volume":"32","author":"Cortes-Canteli","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"35","key":"10.14283\/jpad.2023.105_bib131","doi-asserted-by":"crossref","first-page":"22519","DOI":"10.1074\/jbc.273.35.22519","article-title":"Identification of a novel recognition sequence for integrin alphaM beta2 within the gamma-chain of fibrinogen","volume":"273","author":"Ugarova","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"10.14283\/jpad.2023.105_bib132","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-142928","article-title":"Fibrinogen-Derived \u03b3377\u2013395 Peptide Improves Cognitive Performance and Reduces Amyloid-\u03b2 Deposition, without Altering Inflammation, in A\u03b2PP\/PS1 Mice","volume":"47","author":"Aso","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"21","key":"10.14283\/jpad.2023.105_bib133","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0960-9822(02)01224-1","article-title":"Tissue-type plasminogen activator is a multiligand cross-beta structure receptor","volume":"12","author":"Kranenburg","year":"2002","journal-title":"Curr Biol"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib134","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2007.06.037","article-title":"Upregulation of tPA\/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease","volume":"423","author":"Lee","year":"2007","journal-title":"Neurosci Lett"},{"issue":"26","key":"10.14283\/jpad.2023.105_bib135","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1523\/JNEUROSCI.23-26-08867.2003","article-title":"The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration","volume":"23","author":"Melchor","year":"2003","journal-title":"J Neurosci"},{"issue":"5","key":"10.14283\/jpad.2023.105_bib136","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/npp.2015.279","article-title":"Tissue-Plasminogen Activator Attenuates Alzheimer's Disease-Related Pathology Development in APPswe\/PS1 Mice","volume":"41","author":"ElAli","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.14283\/jpad.2023.105_bib137","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat Genet"},{"issue":"8","key":"10.14283\/jpad.2023.105_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081890","article-title":"Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease","volume":"10","author":"Grossmann","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.14283\/jpad.2023.105_bib139","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3233\/JAD-200610","article-title":"Anticoagulants for Treatment of Alzheimer's Disease","volume":"77","author":"Grossmann","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"17","key":"10.14283\/jpad.2023.105_bib140","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.0550-04.2004","article-title":"Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer's disease","volume":"24","author":"Bergamaschini","year":"2004","journal-title":"J Neurosci"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib141","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.nbd.2010.06.008","article-title":"Enoxaparin treatment administered at both early and late stages of amyloid \u03b2 deposition improves cognition of APPswe\/PS1dE9 mice with differential effects on brain A\u03b2 levels","volume":"40","author":"Timmer","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.14283\/jpad.2023.105_bib142","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnagi.2013.00019","article-title":"Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia","volume":"5","author":"Tripathy","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"10.14283\/jpad.2023.105_bib143","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jneuroim.2016.05.018","article-title":"Differential effects on glial activation by a direct versus an indirect thrombin inhibitor","volume":"297","author":"Marangoni","year":"2016","journal-title":"J Neuroimmunol"},{"issue":"15","key":"10.14283\/jpad.2023.105_bib144","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.jacc.2019.07.081","article-title":"Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model","volume":"74","author":"Cortes-Canteli","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.14283\/jpad.2023.105_bib145","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1084\/jem.20131751","article-title":"A novel Abeta-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice","volume":"211","author":"Ahn","year":"2014","journal-title":"J Exp Med"},{"issue":"6","key":"10.14283\/jpad.2023.105_bib146","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/eurheartj\/ehx579","article-title":"Less dementia with oral anticoagulation in atrial fibrillation","volume":"39","author":"Friberg","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib147","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2141.1999.01681.x","article-title":"Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia","volume":"107","author":"Lak","year":"1999","journal-title":"Br J Haematol"},{"key":"10.14283\/jpad.2023.105_bib148","article-title":"A Double-blind, Randomized, Placebo-controlled Phase 1 Study to Assess the Safety Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of THN391 in Healthy Subjects","author":"Therini_Bio","year":"2023","journal-title":"Investigator's Brochure"},{"key":"10.14283\/jpad.2023.105_bib149","doi-asserted-by":"crossref","DOI":"10.1177\/17590914221131446","article-title":"Defibrinogenation Ameliorates Retinal Microgliosis and Inflammation in A CX3CR1-Independent Manner","volume":"14","author":"Sarker","year":"2022","journal-title":"ASN Neuro"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib150","first-page":"100","article-title":"Pathological drivers of neurodegeneration in suspected non-Alzheimer's disease pathophysiology. Alzheimer's Res","volume":"13","author":"Wisse","year":"2021","journal-title":"Ther"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib151","first-page":"36","article-title":"Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-\u03b2 and \u03b1-synuclein pathologies in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol","volume":"10","author":"Fixemer","year":"2022","journal-title":"Commun"},{"issue":"1","key":"10.14283\/jpad.2023.105_bib152","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12974-020-01907-0","article-title":"Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration","volume":"17","author":"Woollacott","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.14283\/jpad.2023.105_bib153","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awad078","article-title":"Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia","author":"Malpetti","year":"2023","journal-title":"Brain"},{"issue":"5","key":"10.14283\/jpad.2023.105_bib154","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1365-2362.2002.00994.x","article-title":"Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier","volume":"32","author":"Fiala","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.14283\/jpad.2023.105_bib155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.wad.0000213844.21001.a2","article-title":"New insight into Alzheimer disease: demonstration of fibrin(ogen)-serum albumin insoluble deposits in brain tissue","volume":"20","author":"Lipinski","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.14283\/jpad.2023.105_bib156","doi-asserted-by":"crossref","first-page":"1064178","DOI":"10.3389\/fnagi.2023.1064178","article-title":"Striatal fibrinogen extravasation and vascular degeneration correlate with motor dysfunction in an aging mouse model of Alzheimer's disease","volume":"15","author":"Berk-Rauch","year":"2023","journal-title":"Front Aging Neurosci"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724001535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724001535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T21:10:10Z","timestamp":1737321010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724001535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":156,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2274580724001535"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2023.105","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrin-Targeting Immunotherapy for Dementia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2023.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}